IDEXX Laboratories, Inc.
IDXX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $51,173 | $43,129 | $34,150 | $33,838 |
| - Cash | $208 | $165 | $164 | $288 |
| + Debt | $256 | $1,237 | $1,059 | $987 |
| Enterprise Value | $51,221 | $44,201 | $35,045 | $34,537 |
| Revenue | $1,105 | $1,109 | $998 | $954 |
| % Growth | -0.4% | 11.1% | 4.6% | – |
| Gross Profit | $683 | $695 | $623 | $571 |
| % Margin | 61.8% | 62.6% | 62.4% | 59.8% |
| EBITDA | $392 | $409 | $352 | $299 |
| % Margin | 35.5% | 36.9% | 35.2% | 31.3% |
| Net Income | $275 | $294 | $243 | $216 |
| % Margin | 24.8% | 26.5% | 24.3% | 22.7% |
| EPS Diluted | 3.4 | 3.63 | 2.96 | 2.62 |
| % Growth | -6.3% | 22.6% | 13% | – |
| Operating Cash Flow | $402 | $186 | $238 | $262 |
| Capital Expenditures | -$31 | -$34 | -$30 | -$39 |
| Free Cash Flow | $371 | $152 | $208 | $223 |